Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: An 18-month open-labeled observational study using HR-pQCT

Quality control for bone quality parameters affected by subject motion in high-resolution peripheral quantitative computed tomography

(2012) Yves Pauchard et al.   BONE

Bisphosphonates for postmenopausal osteoporosis

(2011) Richard Eastell et al.   BONE

Femoral strength in osteoporotic women treated with teriparatide or alendronate

(2011) Tony M. Keaveny et al.   BONE

Teriparatide in Bisphosphonate-Resistant Osteoporosis: Microarchitectural Changes and Clinical Results After 6 and 18 months

(2011) B. Jobke et al.   CALCIFIED TISSUE INTERNATIONAL

Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis

(2011) R. Rizzoli et al.   OSTEOPOROSIS INTERNATIONAL

Reproducibility of direct quantitative measures of cortical bone microarchitecture of the distal radius and tibia by HR-pQCT

(2010) Andrew J. Burghardt et al.   BONE

Carboxyl-terminal parathyroid hormone peptide (53-84) elevates alkaline phosphatase and osteocalcin mRNA levels in SaOS-2 cells

(2010) M. Kung Sutherland et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate

(2010) Ego Seeman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover

(2010) Andrew J Burghardt et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Age-related patterns of trabecular and cortical bone loss differ between sexes and skeletal sites: A population-based HR-pQCT study

(2010) Heather M Macdonald et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis

(2010) H. M. Macdonald et al.   OSTEOPOROSIS INTERNATIONAL

Improvements in Vertebral Body Strength Under Teriparatide Treatment Assessed In Vivo by Finite Element Analysis: Results From the EUROFORS Study

(2009) Christian Graeff et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Intratrabecular tunneling increases trabecular number throughout the skeleton of ovariectomized rhesus monkeys treated with parathyroid hormone 1–84

(2008) M.A. Miller et al.   BONE

Femoral Bone Strength and Its Relation to Cortical and Trabecular Changes After Treatment With PTH, Alendronate, and Their Combination as Assessed by Finite Element Analysis of Quantitative CT Scans

(2008) Tony M Keaveny et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment

(2008) Barbara M Obermayer-Pietsch et al.   JOURNAL OF BONE AND MINERAL RESEARCH